Archive

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

Cabometyx + atezolizumab CBNPC 2L1
Cabometyx + atezolizumab CHC 1L
Cabometyx® + atezolizumab Tumeurs solides
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023